Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections

NCT06731790 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT06731790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06731790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
April 24, 2025
Completion date
September 1, 2025
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute necrotizing encephalopathy, rare genetic disease